Found 5 matching trials
A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors PHASE1 This is a single-center, single-arm ,open-label ,dose escalation and dose e...
Show More Location
Multiple Locations
Learn More & Join Trial
A Clinical Study of CHT101 in CD70-Positive Advanced Solid Tumors PHASE1 Evaluate the safety and efficacy of CD70-targeting UCAR-T cells in the trea...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
A Phase I, Single-arm, Open-label Clinical Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of CHT101 Cell Infusion in Adult Subjects With Recurrent or Progressive Malignant Primary Brain Tumors(CROWN) PHASE1 Recurrent or progressive primary malignant brain tumors are among the malig...
Show More Location
Multiple Locations
Learn More & Join Trial
Universal Anti-CD70 CAR-T (CHT101) Cell Therapy for Relapsed Refractory Systemic Lupus Erythematosus EARLY_PHASE1 This investigator-initiated trial aims to evaluate the safety and efficacy ...
Show More Location
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Learn More & Join Trial
A Clinical Study of CHT101 in CD70-Positive Relapsed or Refractory Hematological Malignancies PHASE1 Evaluate the Safety, Pharmacokinetics and Efficacy of CHT101 in Subjects Wi...
Show More Location
Tianjin Medical University Cancer Institute & Hospital
Learn More & Join Trial